A Prospective Study of Stapokibart Injection in Patients With Seasonal Allergic Rhinitis (SAR)
Clinical trial NCT07459556 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07459556
- Sponsor
- Chengdu Kangnuoxing Biopharma,Inc.
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-03-01
- Primary completion
- 2027-12-01
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.